ArticleBone marrow transplantation2020
Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group.
Abstract readConsensus Statement
In one paragraph
Article in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
51 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Clinical effects of ursodeoxycholic acid in COVID-19 infection: a systematic review and dose-response meta-analysis.Frontiers in pharmacology · 2026Pooled it
- Trial
- Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial.Journal of cancer research and clinical oncology · 2023Trial
- Article
- Time to resolution of veno-occlusive disease/sinusoidal obstruction syndrome post-HCT in defibrotide-treated adults from two European registries.Bone marrow transplantation · 2026Observational
- Evaluation of Prophylactic Defibrotide Use in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multicenter Retrospective Cohort Study.Journal of personalized medicine · 2026Article
- Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.Current oncology (Toronto, Ont.) · 2026Article
- Comprehensive management of hematopoietic stem cell transplantation complications: from infection prevention to immune microenvironment reconstruction.Frontiers in immunology · 2026Review
- Article
- Utility of tolvaptan sodium phosphate for refractory fluid retention in post-transplant sinusoidal obstruction syndrome.International journal of hematology · 2025Article
- Community perceptions and practices on hepatic veno-occlusive disease in Tigray, Ethiopia: An explorative study challenging the attribution to Ageratum conyzoides.PLoS neglected tropical diseases · 2025Article
- Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis.American journal of hematology · 2025Article
- Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.Biomolecules · 2025Review
- Article
- CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant-A Podcast.Targeted oncology · 2025Article
- Kidney Disease and Hematopoietic Stem Cell Transplantation.Kidney360 · 2025Review
- Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients.Frontiers in oncology · 2025Article
- Prognostic Value of the Pretransplant Fibrosis-4 Index on Non-Relapse and Overall Mortality following Unrelated Single-Unit Cord Blood Transplantation in Adults.Acta haematologica · 2025Article
- Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations.Frontiers in oncology · 2025Article
- Late-Onset Veno-Occlusive Disease (VOD) Post Haploidentical Transplant: A Diagnostic Challenge Requiring Liver Biopsy- A Case Report.Mediterranean journal of hematology and infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
39 authors.
Mohamad MohtyHematology Department, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France. mohamad.mohty@inserm.fr.
Florent MalardHematology Department, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.
Manuel AbecasisInstituto Portugues de Oncologia, Lisbon, Portugal.
Erik AertsDepartment of Internal Medicine-Oncology, University Hospital Zurich, Zurich, Switzerland.
Ahmed S AlaskarDepartment of Oncology, King Abdulaziz Medical City, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Mahmoud AljurfKing Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Mutlu AratHSCT Unit, Sisli Florence Nightingale Hospital, Istanbul, Turkey.
Peter BaderDivision for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany.
Frederic BaronDepartment of Hematology, University of Liege, Liege, Belgium.
Grzegorz BasakMedical University of Warsaw, Warsaw, Poland.
Ali BazarbachiDepartment of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Didier BlaiseTransplant and Cellular Immunotherapy Program, Department of Hematology, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France.
Fabio CiceriHematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, University Vita-Salute, Milano, Italy.
Selim CorbaciogluDepartment of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany.
Jean-Hugues DalleDepartment of Hematology and Immunology, Hospital Robert Debre, Paris 7-Paris Diderot University, Paris, France.
Fiona DignanDepartment of Clinical Haematology, Central Manchester Foundation Trust, Manchester, UK.
Takahiro FukudaHSCT Division, National Cancer Center Hospital, Tokyo, Japan.
Anne HuynhHematology Department, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
Jurgen KuballDepartment of Haematology, University Medical Centre, Utrecht, The Netherlands.
Silvy LachanceDepartment of Hematology and Stem Cell Transplant Program, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, QC, Canada.
Hillard LazarusCase Western Reserve University, Cleveland, OH, USA.
Tamas MassziDepartment of Hematology and Stem Cell Transplantation, St. Istvan and St. Laszlo Hospital, Budapest 3 Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
Mauricette MichalletHematology Department, Groupement Hospitalier Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon EST, Pierre Bénite, France.
Arnon NaglerHematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Mairead NiChonghaileNational Stem Cell Transplant Unit (Adults), Department of Haematology, St James's Hospital and Academic Department of Haematology, Trinity College Dublin, Dublin, Ireland.
Shinichiro OkamotoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Antonio PagliucaDepartment of Haematological Medicine, King's College Hospital, London, UK.
Christina PetersDepartment of Pediatrics, St. Anna Kinderspital, 1090, Vienna, Austria.
Finn B PetersenLDS Hospital, Salt Lake City, UT, USA.
Paul G RichardsonDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Tapani RuutuClinical Research Institute, Helsinki University Hospital, Helsinki, Finland.
Wael SaberCenter for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA.
Bipin N SavaniHematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, TN, USA.
Robert SoifferDivision of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
Jan StyczynskiPediatric Hematology and Oncology, University Hospital, Collegium Medicum UMK, Bydgoszcz, Poland.
Elisabeth WallhultSection of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
Ibrahim Yakoub-AghaCHU de Lille, LIRIC INSERM U995, Université de Lille2, Lille, France.
Rafael F DuarteDepartment of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Enric CarrerasHematology Department, Josep Carreras Foundation and Leukemia Research Institute, Hospital Clínic, Barcelona, Spain.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseVascular DiseasesAdultHumansPolydeoxyribonucleotidesPolydeoxyribonucleotides
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.